Recent Updates
Recently added Catalysts
STRO Positive Sentiment

16th Annual World ADC London Summit – Presentation

Key Takeaway: The 16th Annual World ADC London Summit featured a presentation by Dr. Hans-Peter Gerber, focusing on the efficacy and safety profiles of dual payload antibody-drug conjugates (ADCs). The presentation emphasized novel linker payloads designed to overcome resistance mechanisms in cancer treatment. This innovative approach showcases advancements in ADC technology.
Price reaction · baseline $20.47 (2026-02-26 close) · hit pre-market · clean, no other STRO news in the window
day 0 close
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation highlights novel approaches in ADC technology.
  • Focus on overcoming resistance mechanisms is promising.
  • Led by an experienced Chief Scientific Officer.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~13 mo
Low dilution risk
Lead asset
STRO-004
Phase 1 · Head and Neck Squamous Cell Carcinoma HNSCC

Full Press Release Details

[et_pb_section fb_built=”1″ _builder_version=”4.16″ custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_post_title author=”off” categories=”off” comments=”off” admin_label=”15th Annual World ADC Conference – Presentation” _builder_version=”4.23.4″ title_level=”h2″ title_text_color=”#0c71c3″ title_font_size=”28px” title_letter_spacing=”1px” title_line_height=”1.4em” meta_text_color=”#000000″ global_colors_info=”{}”][/et_pb_post_title][et_pb_divider color=”#0badbc” divider_weight=”2px” _builder_version=”4.16″ global_colors_info=”{}”][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font_size=”19px” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]
Spotlighting Efficacy & Safety Profiles of Dual Payload ADCs Featuring Novel Linker Payloads to Overcome Resistance Mechanisms
Presenter: Hans-Peter Gerber, Ph.D., Chief Scientific Officer
[/et_pb_text][et_pb_button button_url=”https://www.sutrobio.com/wp-content/uploads/2026/02/2026-World-ADC_HP-Gerber_Plenary_Final.pdf” url_new_window=”on” button_text=”Presentation” button_alignment=”left” admin_label=”Presentation – Button” _builder_version=”4.27.4″ _module_preset=”default” custom_button=”on” button_text_size=”18px” button_text_color=”#0C71C3″ button_bg_color=”#FFFFFF” button_border_width=”1px” button_border_color=”#0C71C3″ button_border_radius=”3px” button_icon=”||divi||400″ button_icon_color=”#0C71C3″ button_on_hover=”off” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_button][et_pb_gallery gallery_ids=”17776,17777,17778,17779,17780,17781,17782,17783,17784,17785,17786,17787,17788,17789,17790,17791,17792,17793,17794,17795,17796,17797,17798,17799,17800,17801,17802,17803,17804,17805,17806,17807,17808,17809,17810,17811″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” pagination_text_color=”#FFFFFF” module_alignment=”center” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_gallery][/et_pb_column][/et_pb_row][/et_pb_section]

Frequently Asked Questions

What was the focus of the presentation at the summit?

The presentation focused on the efficacy and safety profiles of dual payload ADCs.

Who presented at the World ADC London Summit?

Dr. Hans-Peter Gerber, the Chief Scientific Officer, presented at the summit.

What is the significance of novel linker payloads?

Novel linker payloads are designed to overcome resistance mechanisms in cancer therapies.

Last updated: Feb 27, 2026